肝斑 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "肝斑" in Japanese language version.

refsWebsite

Global rank Japanese rank

23nih.gov

4^th place

24^th place

14doi.org

2^nd place

6^th place

1skintherapyletter.com

low place

1aafp.org

1,916^th place

5,752^nd place

1google.co.jp

934^th place

57^th place

aafp.org

Marc Tunzi, Gary R. Gray (2007-1). “Common skin conditions during pregnancy”. American family physician 75 (2): 211–218. PMID 17263216.

doi.org

Arun Achar, Sanjay K. Rathi (2011-7). “Melasma: a clinico-epidemiological study of 312 cases”. Indian journal of dermatology 56 (4): 380–382. doi:10.4103/0019-5154.84722. PMC 3178998. PMID 21965843.
Sehgal VN, Verma P, Srivastava G et al (2011-12). “Melasma: treatment strategy”. Journal of cosmetic and laser therapy 13 (6): 265–279. doi:10.3109/14764172.2011.630088. PMID 21981383.
長沼雅子「香粧品の有効性の歴史的変遷」『日本香粧品学会誌』第39巻第4号、2015年、275-285頁、doi:10.11469/koshohin.39.275。
Qianyun Chai, Yutong Fei, Huijuan Cao, Congcong Wang, Jinzhou Tian, Jianping Liu (2015-8). “Acupuncture for melasma in women: a systematic review of randomised controlled trials”. Acupuncture in medicine : journal of the British Medical Acupuncture Society 33 (4): 254–261. doi:10.1136/acupmed-2014-010633. PMID 25900923.
Aurangabadkar S J (2019). “Optimizing Q-switched lasers for melasma and acquired dermal melanoses”. Indian journal of dermatology, venereology and leprology 85 (1): 10–17. doi:10.4103/ijdvl.IJDVL_1086_16. PMID 30027914.
Hassan I, Bashir S, Taing S (2015). “A clinical study of the skin changes in pregnancy in kashmir valley of north India: a hospital based study”. Indian journal of dermatology 60 (1): 28–32. doi:10.4103/0019-5154.147782. PMC 4318058. PMID 25657393.
Ennes, SBP; Paschoalick, RC; Alchorne, M Mota De Avelar (2009). “A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma”. Journal of Dermatological Treatment 11 (3): 173–179. doi:10.1080/09546630050517333.
Ogbechie-Godec OA, Elbuluk N (2017-9). “Melasma: an Up-to-Date Comprehensive Review”. Dermatology and therapy 7 (3): 305–318. doi:10.1007/s13555-017-0194-1. PMC 5574745. PMID 28726212.
Huh CH, Seo KI, Park JY et al (2003). “A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma”. Dermatology (Basel, Switzerland) 206 (4): 316–320. doi:10.1159/000069943. PMID 12771472.
葛西健一郎「低フルエンスピコ秒アレキサンドライトレーザー治療の効果と問題点」『日本レーザー医学会誌』第39巻第2号、2018年、131-136頁、doi:10.2530/jslsm.jslsm-39_0016。
Ando H, Matsui MS, Ichihashi M. (2010-6). “Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders”. International journal of molecular sciences 11 (6): 2566–2575. doi:10.3390/ijms11062566. PMID 20640168.
Budamakuntla L, Loganathan E, Suresh DH (2013-7). “A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma”. Journal of cutaneous and aesthetic surgery 6 (3): 139–143. doi:10.4103/0974-2077.118403. PMC 3800287. PMID 24163529.
Fabbrocini G1, De Vita V, Fardella N et al (2011). “Skin needling to enhance depigmenting serum penetration in the treatment of melasma”. Plastic surgery international 2011: 158241. doi:10.1155/2011/158241. PMC 3335478. PMID 22567235. https://doi.org/10.1155/2011/158241.
Hofny ERM, Abdel-Motaleb AA, Ghazally A; et al (2019-6). “Platelet-rich plasma is a useful therapeutic option in melasma”. The Journal of dermatological treatment 30 (4): 396–401. doi:10.1080/09546634.2018.1524821. PMID 30220226.

google.co.jp

books.google.co.jp

朝田康夫、鈴木一成『コスメティックQ&A事典―化粧品のすべてがわかる』（全面改訂最新版）中央書院、2011年、14-15頁。ISBN 978-4-88514-043-3。

nih.gov

pubmed.ncbi.nlm.nih.gov

Arun Achar, Sanjay K. Rathi (2011-7). “Melasma: a clinico-epidemiological study of 312 cases”. Indian journal of dermatology 56 (4): 380–382. doi:10.4103/0019-5154.84722. PMC 3178998. PMID 21965843.
Sehgal VN, Verma P, Srivastava G et al (2011-12). “Melasma: treatment strategy”. Journal of cosmetic and laser therapy 13 (6): 265–279. doi:10.3109/14764172.2011.630088. PMID 21981383.
B. Sofen, G. Prado, J. Emer (2016-1). “Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion”. Skin therapy letter 21 (1): 1–7. PMID 27224897.
Qianyun Chai, Yutong Fei, Huijuan Cao, Congcong Wang, Jinzhou Tian, Jianping Liu (2015-8). “Acupuncture for melasma in women: a systematic review of randomised controlled trials”. Acupuncture in medicine : journal of the British Medical Acupuncture Society 33 (4): 254–261. doi:10.1136/acupmed-2014-010633. PMID 25900923.
Aurangabadkar S J (2019). “Optimizing Q-switched lasers for melasma and acquired dermal melanoses”. Indian journal of dermatology, venereology and leprology 85 (1): 10–17. doi:10.4103/ijdvl.IJDVL_1086_16. PMID 30027914.
Hassan I, Bashir S, Taing S (2015). “A clinical study of the skin changes in pregnancy in kashmir valley of north India: a hospital based study”. Indian journal of dermatology 60 (1): 28–32. doi:10.4103/0019-5154.147782. PMC 4318058. PMID 25657393.
Marc Tunzi, Gary R. Gray (2007-1). “Common skin conditions during pregnancy”. American family physician 75 (2): 211–218. PMID 17263216.
Nestor M, Bucay V, Callender V; et al (2014-3). “Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders”. The Journal of clinical and aesthetic dermatology 7 (3): 13–17. PMC 3970827. PMID 24688621.
Ogbechie-Godec OA, Elbuluk N (2017-9). “Melasma: an Up-to-Date Comprehensive Review”. Dermatology and therapy 7 (3): 305–318. doi:10.1007/s13555-017-0194-1. PMC 5574745. PMID 28726212.
Jasmine C. Hollinger, Kunal Angra, Rebat M. Halder (2018-2). “Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review”. The Journal of clinical and aesthetic dermatology 11 (2): 28–37. PMC 5843359. PMID 29552273.
Huh CH, Seo KI, Park JY et al (2003). “A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma”. Dermatology (Basel, Switzerland) 206 (4): 316–320. doi:10.1159/000069943. PMID 12771472.
Ando H, Matsui MS, Ichihashi M. (2010-6). “Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders”. International journal of molecular sciences 11 (6): 2566–2575. doi:10.3390/ijms11062566. PMID 20640168.
Budamakuntla L, Loganathan E, Suresh DH (2013-7). “A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma”. Journal of cutaneous and aesthetic surgery 6 (3): 139–143. doi:10.4103/0974-2077.118403. PMC 3800287. PMID 24163529.
Fabbrocini G1, De Vita V, Fardella N et al (2011). “Skin needling to enhance depigmenting serum penetration in the treatment of melasma”. Plastic surgery international 2011: 158241. doi:10.1155/2011/158241. PMC 3335478. PMID 22567235. https://doi.org/10.1155/2011/158241.
Hofny ERM, Abdel-Motaleb AA, Ghazally A; et al (2019-6). “Platelet-rich plasma is a useful therapeutic option in melasma”. The Journal of dermatological treatment 30 (4): 396–401. doi:10.1080/09546634.2018.1524821. PMID 30220226.

ncbi.nlm.nih.gov

Arun Achar, Sanjay K. Rathi (2011-7). “Melasma: a clinico-epidemiological study of 312 cases”. Indian journal of dermatology 56 (4): 380–382. doi:10.4103/0019-5154.84722. PMC 3178998. PMID 21965843.
Hassan I, Bashir S, Taing S (2015). “A clinical study of the skin changes in pregnancy in kashmir valley of north India: a hospital based study”. Indian journal of dermatology 60 (1): 28–32. doi:10.4103/0019-5154.147782. PMC 4318058. PMID 25657393.
Nestor M, Bucay V, Callender V; et al (2014-3). “Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders”. The Journal of clinical and aesthetic dermatology 7 (3): 13–17. PMC 3970827. PMID 24688621.
Ogbechie-Godec OA, Elbuluk N (2017-9). “Melasma: an Up-to-Date Comprehensive Review”. Dermatology and therapy 7 (3): 305–318. doi:10.1007/s13555-017-0194-1. PMC 5574745. PMID 28726212.
Jasmine C. Hollinger, Kunal Angra, Rebat M. Halder (2018-2). “Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review”. The Journal of clinical and aesthetic dermatology 11 (2): 28–37. PMC 5843359. PMID 29552273.
Ando H, Matsui MS, Ichihashi M. (2010-6). “Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders”. International journal of molecular sciences 11 (6): 2566–2575. doi:10.3390/ijms11062566. PMID 20640168.
Budamakuntla L, Loganathan E, Suresh DH (2013-7). “A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma”. Journal of cutaneous and aesthetic surgery 6 (3): 139–143. doi:10.4103/0974-2077.118403. PMC 3800287. PMID 24163529.
Fabbrocini G1, De Vita V, Fardella N et al (2011). “Skin needling to enhance depigmenting serum penetration in the treatment of melasma”. Plastic surgery international 2011: 158241. doi:10.1155/2011/158241. PMC 3335478. PMID 22567235. https://doi.org/10.1155/2011/158241.

skintherapyletter.com

B. Sofen, G. Prado, J. Emer (2016-1). “Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion”. Skin therapy letter 21 (1): 1–7. PMID 27224897.